Simplifying and strengthening diagnostics in 2023

Simplifying and strengthening diagnostics in 2023


Leveraging our passion and curiosity for science to deliver industry-leading solutions.

December 20, 2023


As we near the end of 2023, we take a moment to reflect on a remarkable year. At Roche Diagnostics, we have made significant progress toward our mission and take pride in being pioneers of diagnostic excellence. 

Together, we delivered transformation through the proven principles of Patient-Centric Partnership, Science-Driven Leadership and Operational Simplicity

Looking back at these 12 months, our journey has been extraordinary. We invite you to join us in this journey as we continue to lead the way in diagnostics.




Patient-Centric Partnership

We continually advance value-based care through collaboration, ensuring our partnerships contribute to positive healthcare outcomes. Together, we provide seamless interactions to simplify needs and enhance patient care. 



Science-Driven Leadership

We bring cutting-edge products and assays to market, ensuring the right test is conducted at the right time. We excel in clinical and digital transformation to address critical healthcare needs when and where they matter most.  

No. 1 Investor in R&D in healthcare | Premier Inc. Innovation Awards winner for the Elecsys® Alzheimer’s Disease CSF biomarker assays | Elecsys® Neurofilament Light Chain test receives FDA Breakthrough Device Designation for the management decisions of certain forms of multiple sclerosis
Operational Simplicity

We focus on bringing simplicity to allow our customers to do more with less. As we continue to grow our integrated portfolio, we will continue to invest in cutting-edge systems to optimize resources and elevate the standards of care.

*For research use only. Not for use in diagnostic procedures.